Transgenic mice expressing dominant-negative TβRII in CD4+ and CD8+ T cells exhibit resistance to tumor growth, indicating the necessity of TGF-β in those T cell lineages for tumor growth [315]. The gene discussed is CD4; the disease is neoplasm.